ENDRA Life Sciences Inc
NASDAQ:NDRA
ENDRA Life Sciences Inc
NASDAQ:NDRA
Price:
4.65
USD
-0.64%
Market Closed
Market Cap:
$5.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
ENDRA Life Sciences Inc
NASDAQ:NDRA
|
US |
|
Cushman & Wakefield PLC
NYSE:CWK
|
UK |
|
V
|
VIS Containers Manufacturing SA
ATHEX:VIS
|
GR |
|
Boku Inc
LSE:BOKU
|
US |
|
S
|
Shenzhen Worldunion Group Inc
SZSE:002285
|
CN |
|
S
|
Shandong Xinchao Energy Corp Ltd
SSE:600777
|
CN |
|
O
|
Outokumpu Oyj
OTC:OUTKY
|
FI |
|
J
|
Jiangsu Sihuan Bioengineering Co Ltd
SZSE:000518
|
CN |
|
A
|
Alphaform AG
OTC:AFRMF
|
DE |
|
F
|
Fox E-Mobility AG
DUS:CT4
|
DE |
|
De' Longhi SpA
OTC:DELHF
|
IT |
Balance Sheet
Balance Sheet Decomposition
ENDRA Life Sciences Inc
ENDRA Life Sciences Inc
Balance Sheet Decomposition is not available for
ENDRA Life Sciences Inc
ENDRA Life Sciences Inc
Balance Sheet
ENDRA Life Sciences Inc
ENDRA Life Sciences Inc
Currency: USD
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
6
|
6
|
6
|
7
|
9
|
5
|
3
|
3
|
|
| Cash |
0
|
0
|
0
|
6
|
6
|
6
|
7
|
9
|
5
|
3
|
3
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
3
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
0
|
6
|
7
|
7
|
8
|
12
|
8
|
3
|
3
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
1
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
0
|
|
| Total Assets |
1
N/A
|
0
-30%
|
0
N/A
|
6
+1 149%
|
7
+18%
|
7
-1%
|
9
+22%
|
13
+47%
|
9
-28%
|
7
-27%
|
4
-34%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
0
|
0
|
0
|
1
|
1
|
1
|
0
|
1
|
1
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
|
| Short-Term Debt |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
1
|
1
|
1
|
2
|
1
|
2
|
2
|
1
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
|
| Total Liabilities |
0
N/A
|
0
+140%
|
1
+475%
|
1
-38%
|
1
+14%
|
2
+149%
|
2
-34%
|
2
+31%
|
2
-1%
|
1
-47%
|
2
+73%
|
|
| Equity | ||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
7
|
10
|
13
|
18
|
28
|
45
|
57
|
69
|
82
|
92
|
103
|
|
| Additional Paid In Capital |
8
|
10
|
12
|
23
|
34
|
50
|
64
|
79
|
89
|
98
|
106
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
1
N/A
|
0
-59%
|
1
N/A
|
5
N/A
|
6
+18%
|
5
-24%
|
7
+51%
|
11
+50%
|
7
-33%
|
6
-21%
|
3
-55%
|
|
| Total Liabilities & Equity |
1
N/A
|
0
-30%
|
0
N/A
|
6
+1 149%
|
7
+18%
|
7
-1%
|
9
+22%
|
13
+47%
|
9
-28%
|
7
-27%
|
4
-34%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
3
|
0
|
1
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
